Original Article

Association between Neuregulin-1 Gene Variant ‎‎(rs2439272) and Schizophrenia and its Negative ‎Symptoms in an Iranian Population

Abstract

Objective: Although the etiology of schizophrenia is unknown, it has a significant genetic component. ‎A number of studies have indicated that neuregulin-1 (NRG1) gene may play a role in the ‎pathogenesis of schizophrenia. In this study, we examined whether the rs2439272 of NRG1 ‎is associated with schizophrenia and its negative symptoms in an Iranian population.‎
Method: Rs2439272 was genotyped in 469 participants including 276 unrelated patients with schizophrenia and 193 healthy controls. The association of genetic risk with PANSS, and negative ‎symptoms was examined in the total, male and female samples. COCAPHASE and ‎CLUMP22 programs were used to compare the allele and genotype frequencies, and ‎general linear regression was used to analyze the quantitative dependent variables by the ‎selected variant.‎
Results: In this study, it was revealed that the G allele of rs2439272 might be an allele with the ‎increased risk of developing schizophrenia, especially in the male participants. In addition, ‎significant differences were found between the G allele and GG genotype frequencies and ‎PANSS, and negative symptoms in the total and male participants.‎
Conclusion: Our results supported the association between rs2439272 in NRG1 gene and risk of ‎schizophrenia and its negative symptoms in an Iranian population.

Yang JZ, Si TM, Ruan Y, Ling YS, Han YH, Wang XL, et al. Association study of neuregulin 1 gene with schizophrenia. Molecular psychiatry 2003; 8: 706-709.

Lin HF, Liu YL, Liu CM, Hung SI, Hwu HG , Chen WJ. Neuregulin 1 gene and variations in perceptual aberration of schizotypal personality in adolescents. Psychol Med 2005; 35: 1589-1598.

Mohamad Shariati SA, Behmanesh M , Galehdari H. A Study of the Association between SNP8NRG241930 in the 5' End of Neuroglin 1 Gene with Schizophrenia in a Group of Iranian Patients. Cell journal 2011; 13: 91-96.

Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. American journal of human genetics 2003; 72: 83-87.

Li D, Collier DA , He L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Human molecular genetics 2006; 15: 1995-2002.

Georgieva L, Dimitrova A, Ivanov D, Nikolov I, Williams NM, Grozeva D, et al. Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biological psychiatry 2008; 64: 419-427.

Greenwood TA, Light GA, Swerdlow NR, Radant AD , Braff DL. Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PloS one 2012; 7: e29630.

Cho Y, Ryu S, Huh I, Cho EY, Oh H, Lee YS, et al. Effects of genetic variations in NRG1 on cognitive domains in patients with schizophrenia and healthy individuals. Psychiatric genetics 2015; 25: 147-154.

Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic acids research 1988;16:1215.

Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genetic epidemiology 2003; 25: 115-121.

Sham PC , Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Annals of human genetics 1995; 59: 97-105.

Roussos P, Giakoumaki SG, Adamaki E , Bitsios P. The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biological psychiatry 2011; 69: 479-486.

Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE , Weinberger DR. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Molecular psychiatry 2004; 9: 299-307.

Chagnon YC, Roy MA, Bureau A, Merette C , Maziade M. Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes. Schizophrenia research 2008; 100: 281-290.

Corfas G, Roy K , Buxbaum JD. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nature neuroscience 2004; 7: 575-580.

Flames N, Long JE, Garratt AN, Fischer TM, Gassmann M, Birchmeier C, et al. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 2004; 44: 251-261.

Neddens J , Buonanno A. Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 2010; 20: 724-744.

Wen L, Lu YS, Zhu XH, Li XM, Woo RS, Chen YJ, et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 1211-1216.

Ting AK, Chen Y, Wen L, Yin DM, Shen C, Tao Y, et al. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. The Journal of neuroscience : the official journal of the Society for Neuroscience 2011; 31: 15-25.

Kim J-J, Crespo-Facorro B, Andreasen NC, O'Leary DS, Magnotta V , Nopoulos P. Morphology of the lateral superior temporal gyrus in neuroleptic naıve patients with schizophrenia: relationship to symptoms. Schizophrenia research 2003; 60: 173-181.

Tosato S, Bellani M, Bonetto C, Ruggeri M, Perlini C, Lasalvia A, et al. Is neuregulin 1 involved in determining cerebral volumes in schizophrenia? Preliminary results showing a decrease in superior temporal gyrus volume. Neuropsychobiology 2012; 65: 119-125.

Skilbeck KJ, Hinton T , Johnston GA. Sex-differences and stress: effects on regional high and low affinity [3H]GABA binding. Neurochemistry international 2008; 52: 1212-1219.

Karatsoreos IN, Bhagat SM, Bowles NP, Weil ZM, Pfaff DW , McEwen BS. Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 2010; 151: 2117-2127.

Zhang H, Li W, Zhang H, Zhang Y, Zhao J, Lv L, et al. [Expressional changes of neuregulin-1 gene mRNA in peripheral blood from schizophrenia patients]. Zhonghua yi xue yi chuan xue za zhi= Zhonghua yixue yichuanxue zazhi= Chinese journal of medical genetics 2011; 28: 620-624.

Réthelyi JM, Bakker SC, Polgár P, Czobor P, Strengman E, Pásztor PI, et al. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010; 153: 792-801.

Files
IssueVol 11 No 3 (2016) QRcode
SectionOriginal Article(s)
Keywords
Negative Symptoms Neuregulin-1 (NRG1) Positive and Negative Syndrome Scale ‎‎ (PANSS) Schizophrenia Single Nucleotide Polymorphism (SNP) ‎

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Yoosefee S, Shahsavand Ananloo E, Joghataei M-T, Karimipour M, Hadjighassem M, Mohaghghegh H, Tehrani-Doost M, Rahimi A-A, Mostafavi Abdolmaleky H, Hatami M. Association between Neuregulin-1 Gene Variant ‎‎(rs2439272) and Schizophrenia and its Negative ‎Symptoms in an Iranian Population. Iran J Psychiatry. 2016;11(3):147-153.